Keywords: elan, reacquires, generic, nifedipine, product, reacquiring, rights

Elan reacquires generic nifedipine product

Article | 28 April 1999

Print This

Elan is reacquiring rights to its extended-release nifedipine product, ageneric form of Bayer's Adalat CC, from Warner Chilcott. The latter ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in